tweetindex
EN

Nature Biotechnology ✓

@NatureBiotech · NY/CA/London/Berlin · joined 03 Jun 2009

Publishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.

325 688Followers
2 769Following
17 479Posts total
54.2KViews on collected posts

Latest posts

Obvious chemical substitutions could be used to generate powerful new composition-of-matter patents, highlighting the need for patent and antitrust policy reforms that better separate strategic pursuit of exclusivity from true therapeutic innovation https://t.co/jf2TbkOsu1 5.8K views · 11 likes · 5 reposts · 0 replies Open on X →
Menstrualome aids difficult endometriosis diagnosis https://t.co/IxgMKOUFTj https://t.co/mBkiAzsbUT https://t.co/zcGAY9jSYC 6.9K views · 4 likes · 2 reposts · 0 replies Open on X →
Recent moves of note in and around the biotech and pharma industries https://t.co/Qy9AmLGo6h https://t.co/JD7BwAyBSI 7.6K views · 2 likes · 0 reposts · 0 replies Open on X →
Ensuring multiomics data reproducibility for artificial intelligence with reference materials as a common calibrator https://t.co/EMBmmfKqXG https://t.co/xo3cKHppVL 10.2K views · 68 likes · 12 reposts · 0 replies Open on X →
@NatureBiotech @kevintzhao93 @QiBiodesign 👍 52 views · 0 likes · 0 reposts · 0 replies Open on X →
Engineered genomic attachment sites for site-specific recombinases enable high-efficiency integration in plants and human cells https://t.co/pMa8oWs1rT https://t.co/j8xqy7xidd 10.8K views · 93 likes · 18 reposts · 1 replies Open on X →
.@n_lorem publishes commentary offering insight into potential commercialization strategies for nano-rare medicines #NBTintheNews https://t.co/o0NFWN60sH 1.3K views · 1 likes · 1 reposts · 0 replies Open on X →
Establishing a commercial solution for extremely rare genetic diseases - @DrStanleyCrooke @AndrewWLo https://t.co/e1NTWMRwAG https://t.co/DZTHQyOIjN
11.6K views · 32 likes · 8 reposts · 1 replies Open on X →

Against accounts of the same size

6 posts from the last 90 days, next to the 100K–1M follower range. shown widely, but few of those viewers react.

Median views7 244this account5 983median for 100K–1M
Reach, %2.22%this account1.49%median for 100K–1M
Engagement, %0.20%this account0.93%median for 100K–1M
MetricThis accountMedian for 100K–1MRatio
Median views per post7 2445 9831.21×
Reach (views ÷ followers)2.22%1.49%1.49×
Engagement rate0.20%0.93%0.21×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

11.6K2 Mar
1.3K23 Mar
10.8K2 Sep
523 Sep
10.2K
7.6K
6.9K
5.8K

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.37%2 Mar
0.15%23 Mar
1.04%2 Sep
0.00%3 Sep
0.80%
0.03%
0.10%
0.29%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes58.3%211 in total
Reposts12.7%46 in total
Replies0.6%2 in total
Quotes1.4%5 in total
Bookmarks27.1%98 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Similar accounts